Clinical Trial Update: Topotecan in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial of topotecan in fallopian tube cancer, ovarian cancer, or primary peritoneal cancer; the study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Topotecan (topotecan)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Fallopian Tube Cancer, Ovarian Cancer | Phase 1 | Status: TERMINATED